Trademark search for:

DIRAZEC

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2008-08-22 — Application filed
2008-11-13 — Sn assigned for sect 66a appl from ib
2008-11-14 — Application filed
2008-11-18 — Application filed
2008-12-02 — Assigned to examiner
2008-12-03 — Approved for pub - principal register
2008-12-10 — Assigned to lie
2008-12-10 — Law office publication review completed
2008-12-24 — Notice of publication
2009-01-13 — Published for opposition
2009-03-31 — Registered-principal register
2011-05-12 — Change of owner received from ib
2015-09-10 — New representative at ib received
2015-11-06 — Cancelled section 71
2016-07-06 — Total invalidation of reg ext protection created
2016-07-08 — Total invalidation of reg ext protection sent to ib
2016-07-08 — Invalidation processed
2017-04-21 — Total invalidation processed by the ib
2018-08-22 — Final status recorded
2019-03-22 — Death of international registration
2019-03-22 — Notification of effect of cancellation of intl reg mailed

Owner Information

Celgene Corporation
US

Astellas Pharma Inc.
JP

Correspondent

TACHIBANA Tetsuo c/o Tachibana International Patent Office
3F, YKB Ensign Building,
28-4, Yotsuya 4 chome,
Tokyo 160-0004,

Filing Details

Filing Date:
2008-08-22

Status Date:
2018-08-22

Category:
Pharmaceuticals

Filing Year:
2008

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.